Member Info for Pingu777

People anticipating that being the bottom. See how tomorrow pans out. News soon please.

Topped up 160,000 shares. Not showing yet.

Toine is worse than a hardcore deramper! He puts everyone off their game!

Sounds my little lad when he’s excited to go to a play gym. He’s not quite there yet.

We raised 1.66 times our annual cash burn in May. Cash flow is not an issue. It was ear marker for Covid and car t IND enabling studies. Imo our prioritisation of these two workflows identify their significance. All GlobalCo work including CDX has been funded by GlobalCo.

Hemo is so small a company with a tiny MCap we have been punching so far above our weight it’s untrue. Our partners are monsters which again is further validation of our work.

The level of trust put in little hemo by the big boys is invaluable. It should demand so much more SP support than it does and again it’s simply not priced in.

Vlad will push the company to new heights in the next few weeks.

You price in success as a 30% rise on a pharma? I seriously think you’re views are misaligned. I’d hope it does 100% on no news over the next month. If CDX is successful then my target is 80p or £300m ish MCap .

Let me know your thoughts on the rest of the year for HEMO.

HEMO can change the oncology space and solve the high AML morbidity levels. Do you get this USP? We do 30% in a day on nothing.

I think you need to get to grips with HEMO IP.

What do you think of the mice for a development platform? Alone it multibags the SP over the coming months.

Hemo is a pre-clinical pharma with exciting products currently. Typically these firms are still super risky as product failure is very common.

However, the timing of the Eli notification provides excellent validation of tech. It says they’re happy that the percentages are in their favour now in terms of success.

And we have to revolutionary and exception ApbHC mice. Like other humanised mice our have human immune systems but unlike others ours live for up to 150 days as opposed to the industry standard and average of 40 days. This means drugs can be much more extensively tested significantly de-risking phase 1 and 2 human trials.

In my eyes and based on these facts human trials phase 1 and 2 are basically a shoe in. Toxicology and doseage will be nailed on in the mice leading to substantially expedited human trials.

But again, the risk of failure massively reduced and this is not factored into the current SP. we are still being valued as traditionally tested pre-clinically tested drug developer. And this we are not.

The mice are next gen tech.

Is the trial success factored into the current SP? lols. £32m MCap. Chemotherapy replacement and potential cure for the deadly AML... I’d suggest probably not.

Confusing to hear you think it’s a good entry point currently but you don’t know if it’s a good investment? Slightly contradictory?

If you are not sure whether it is then you need to read up more on the product portfolio and progress to date.

Pharma is about treatments/drugs with USPS and are novel, market leaders. A significant market to sell into. Do something no other has quite mastered yet.

I think if you spend enough time reading up on HEMO you’ll discover its X factor products will be worth waiting for.

True value will be crystallised on a Covid product released (v short term) and then on details of the CDX deal and then successful human testing before the end of the year. Lives saved with a ground breaking chemo-free treatment.

The announcement of Eli has been undervalued by the market imo as it heavily validates our work and further reduces the chances of failure.

Bored of having to go over it all to be honest but trying to add a modicum of helpfulness . People need to do more research if you’re not sure of HEMOs potential.

Pumpky I have a tip mate. Find out the placing prices of the shares you invest in and record how long ago it was. Can be useful information. Also regarding the £100k sell, what happened was someone bought lots of shares at some point. And then they sold them. That’s how it works. Fortunately for us there must have been plenty of buying as it didn’t completely tank the share Price.

#invladwetrust

Pumpky, why are you here?

The consortium that CTEA are involved in have bright contacts and fingers in enough pies in the city to have a serious shortlist of clients prepped a while ago. Implementing the app simply cannot happen over night. It will be taking CTEA et al a bit of time to sort but they have a legitimate shout at delivering a valuable asset here.

Once the first few companies are onboard it may well snowball as take-up-businesses get back to near-full-speed quicker. Could be a scramble at some point.

hope CTEA have put together a decent sales team to handle things.

The Lilly deal is massive. The validation this brings to the CDX as well as the ApbHC development platform AND the lupus model and treatment work is huge. And yet it has been overshadowed by an poorly executed Q&A intended to remind people of the key points with HEMO at the mo. Everyone seems to completely overlook the vast array of product lines we are working on and dwell on the take away that they weren't clear about the three month extension to the end of August (1 Sept).

I for one was impressed with Vlads highlighting of the fact we re going it alone with our Covid work. It says to me have something Bug pharma might want from us, something novel. Hoping to see a T CELL test in the next few weeks that blows the current testing market out of the water. I noticed there was reference to a vaccine on the slides he shared. With Marc Feldmanns specialist background in combo with our antibody work I wonder they have been working on?!?!

And also if Eli haven't used our mice for testing their Covid antibody candidates then I'll eat my hat. Even if that generates no commercial income the implications/validation will be significant.

Now this is what I was hoping to see. Some actual quotes! Its not about any big new pieces of news, its about the nuances you pick up on and the specific quotes from Vlad that help to paint a picture.

This info is now out there and it is positive. But this should not be an echo chamber and if anyone can dispute these points let it be heard. This BB should be about truth and facts not colluding derampers and misinformation.

Good job Manifesto, it certainly is needed.

Bogyo, its a matter of principle. I am in for 12 months plus FYI.

Is an additional three month delay a piece of news material to the SP? I refuse to believe the interpretations of someone who didn't properly listen to the webinar. That is all.

No one else has mentioned this delay in any other share chat or that I have seen on social media etc. But the guy who wasn't paying attention says its a definite?!

I simply suggest opinions of Vlad releasing material news via the Q&A should be taken with a pinch of salt. I might not be invested as long as Ontarget but I am not bad at reading. I'll stick to the info in RNSs cheers.

Nothings changed here. Oh apart from we're partnered up with a BIG PHARMA. Other than that, still full steam ahead.

You are correct I could not get on the webinar yesterday because of people like you who logged in and then conveniently didn't quite listen at the right time or misheard him referencing mice or there could be further delays due to covid or … etc etc etc
If anything had materially changed it would need to formally released in an RNS. I know what I know from reading all previous news. And your version of info is materially different to what I know. Which is not possible.

I'm sure readers will make their own mind up as to who is being liberal with the truth.

Oh, and what did you say you sold for yesterday?

OnTarget, price did you get yesterday for your shares?

What is this talk of a 3 months extension to the extension that might get extended? I smell something stinky and rhymes with dull twit.

Nothing has changed from pre-Q&A. everyone knows Eli paused their human trials end of March and now everyone knows they're back going again.

two mice sales?!?!! haha

This is a plain deramp (whether intentional or otherwise). This is why the farce of a Q&A going out to 100 people is one of the worst ideas I've ever seen as it leads to quite simply terrible information sharing.

You Ontarget are now firmly on my "do not trust" list.

Was busy all day yesterday but thanks for the responses. Just what I wanted to hear. Not a direct rival of a product as they provide different benefits! Excellent!
Excited to see the results. Hopefully not so long now.

Just to clarify this is not a big deramp but just interested to hear peoples views. Imo the market looks easily big enough for multiple players.